cerrar
Tagged with UK

5 HTA Trends to Watch from UK NICE Chief Executive Samantha…
Since its creation over 20 years ago, the National Institute for Health and Care Excellence (NICE), the Health Technology Assessment (HTA) body for…

UK Science Gets a Boost With Rejoining of Horizon Europe: What…
Could the UK’s re-joining of Horizon Europe, the EU’s EUR 95 billion research funding programme, be the latest sign that the country is ready to…

UK Pharma News: Novo Nordisk Safety Review; AstraZeneca/Quell…
The latest news from UK healthcare and life sciences, including the safety review of Novo Nordisk's GLP-1 receptor agonists; VaxEquity's grant to…

Rodrigo Rodriguez – Area Head UMEA, Takeda
Rodrigo Rodriguez, as area head for UMEA at Takeda, leads a vast and varied region that includes Ukraine, the Middle East and Africa and is…

Jean-Louis Laurent Josi – CEO, Sukoon Insurance
‘Sukoon’ means ‘tranquillity’ and ‘peace of mind’ in Hindi, Arabic and Urdu which perfectly reflects the recently rebranded Sukoon…

Can the UK’s New Life Sciences Plan Save Its Global…
Life sciences have been steadily losing ground in the UK with a significant drop in global R&D investments and a decreasing number of patients…

UK Healthcare & Pharma News: Life Sciences Plan Takes Shape;…
The latest news from UK healthcare and the life sciences, including a record rise in the number of people using private healthcare services due to…

Ossama Salah Ramadan – Gulf Manager, Tabuk Pharmaceuticals
Tabuk Pharmaceuticals is a Saudi success story, now established as one of the GCC region's leading private pharmaceutical companies. Gulf Manager…

Maintaining Good Clinical Practice During War
Igor Bondarenko of Ukraine's Dnipro State Medical University, Evgeny Levenko from clinical trials company, ARENSIA, and Olena Popova from IQVIA offer…

Ethical Considerations: Clinical Research in Wartime Ukraine and…
The March edition of DIA’s Global Forum magazine features a special section on clinical research in Ukraine, over one year on from the beginning of…

From COVID-19 Pandemic to War: Clinical Trial Industry Powers on…
The March edition of DIA’s Global Forum magazine features a special section on clinical research in Ukraine, over one year on from the beginning of…

UK Pharma Industry Warns of Declining Competitiveness
The UK government has decided to go ahead with a much-debated increase in the revenue clawback rate —from 24.4 percent to 27.5 percent— for…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here